Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04596254 · ClinicalTrials.gov registry record · NA

Detection of Gut Metabolites in Mother's Milk Following Juice Intake

A NA study, sponsored by Amazentis.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT04596254 is a NA study that has completed, run by Amazentis. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04596254, a NA study, has completed, sponsored by Amazentis.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The goal of the biological sample collection is to assess the presence of gut metabolites in human breast milk (BM) samples obtained prospectively from healthy lactating mothers and after consumption of fruit juice.

Interventions

  • OTHER Pomegranate Juice

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2020-10-15
Est. Completion 2022-12-31
Phase NA

Sponsor

Amazentis

5 total trials

What the Registry Record Tells You About NCT04596254

The ClinicalTrials.gov registry entry for NCT04596254 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amazentis, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pomegranate Juice is the first listed.

NCT04596254 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04596254 about?

NCT04596254 is a clinical study titled "Detection of Gut Metabolites in Mother's Milk Following Juice Intake". The goal of the biological sample collection is to assess the presence of gut metabolites in human breast milk (BM) samples obtained prospectively from healthy lactating mothers and after consumption of fruit juice.

What is the current status of trial NCT04596254?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2020-10-15. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04596254?

The interventions under investigation include: Pomegranate Juice (OTHER).

Who is sponsoring clinical trial NCT04596254?

This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.